Cooper Companies | COO - Liquidités





Liquidités Changement Date
Abbott USD 6.8B 1.72B 2026-03
Align Technology USD 1.06B 35.07M 2026-03
AtriCure USD 167.79M 21.62M 2026-06
Bausch Health Companies USD 1.83B 526M 2026-06
Baxter International USD 2.15B 133M 2026-06
Bayer EUR 5.73B 943M 2026-03
Becton, Dickinson and Co. USD 813M 73M 2026-03
Boston Scientific USD 539M 914M 2026-06
Cooper Companies USD 124.9M 14.3M 2025-12
Dentsply International USD 190M 136M 2026-03
Dexcom USD 1.1B 13.2M 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
Globus Medical USD 560.95M 34.79M 2026-03
Haemonetics USD 245.44M 117.93M 2026-03
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 534.9M 54.5M 2026-06
Integra LifeSciences USD 214.42M 22.39M 2026-06
Intuitive Surgical USD 8.63B 646.3M 2026-06
J&J USD 20.42B 1.27B 2026-06
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 448.7M 39.38M 2026-06
Novartis USD 6.88B 2.68B 2026-03
ResMed USD 1.66B 243.44M 2026-03
STAAR Surgical USD 153.15M 23M 2025-12
Steris USD 439.6M 15.9M 2026-03
Stryker USD 3.39B 513M 2026-06
Tandem Diabetes Care USD 179.32M 88.69M 2026-03
Teleflex USD 309.41M 69.15M 2026-03
Utah Medical Products USD 84.27M 2.09M 2025-09
Zimmer Biomet Holdings USD 410M 14.2M 2026-06